Tirzepatide substance synthesis presents a complex challenge due to its complex chemical structure. Chemists are continuously striving to optimize the manufacture process, aiming for high yields and purity while minimizing impacts. Once synthesized, Tirzepatide API requires a robust supply chain infrastructure to ensure timely shipment to patients